Skip to main content

Table 2 Characteristics of headache after vaccination in study population (n = 334)

From: Headache following vaccination against COVID-19 among healthcare workers with a history of COVID-19 infection: a cross-sectional study in Iran with a meta-analytic review of the literature

Prevalence of post-vaccination headache (%)

131 (39.2)

Previous history of headache (%)

Migraine

67 (51.1)

Tension

36 (27.4)

Other types

28 (21.5)

Mean time of occurring headache after vaccination, hour

26.78 ± 6.93

Form of headache after vaccination (%)

Early (≤ 24 h)

109 (83.2)

24 to 72 h)

10 (7.6)

72 h to 7 days

8 (6.1)

> 72 h

4 (3.1)

The mean duration of headache (hour)

4.22 ± 1.26

Pattern of post-vaccination headache (%)

Pressing

97 (74.0)

Pulsatile

22 (16.8)

Neurologic type

12 (9.2)

Location of post-vaccination headache (%)

Frontal

14 (10.7)

Temporal

13 (9.9)

Occipital

4 (3.1)

Parietal

7 (5.3)

Diffuse

43 (32.8)

Neck

1 (0.7)

Mixed

49 (37.5)

Other symptoms along with headache (%)

Nausea

21 (9.2)

Photophobia

6 (4.6)

Sensitivity to sound

9 (6.9)

Medication used for headache relief (%)

Acetaminophen

65 (49.6)

Ibuprofen

17 (12.9)

Naproxen

16 (12.2)

Other analgesics

24 (18.3)